NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
29/12/2025
Voltar para busca
Dado oficial do USPTO
EVALUATE MEDTECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EVALUATE MEDTECH
ST13
US500000085715369Classe
35, 41
Pedido
85715369
Registro
4815514
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
72
Atualização mais recente
20/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41
Data de depósito
28/08/2012
Data de registro
22/09/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/12/2025
Última transação
20/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
LONDON, GB
Examinador
TIERNEY, MARGERY
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PHARMA INTELLIGENCE U.K. LIMITED
EVALUATE GROUP LIMITED
Evaluate Ltd
Representantes
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Classificação técnica
Classes Nice
Classe 35Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising services; business management; business administration consulting services; marketing services; advertising services provided via the Internet; accountancy services; public opinion polling services; provision of business information; advisory services relating to business management and organisation; commercial and industrial management assistance; collectionanalysis and provision of business information; business consultancy; consultancy relating to the preparation of business statisticsstructure and forward planning; advertising services relating to the field of medicine; business due-diligence services; product merchandising; advertising agenciespromoting the services of companies in the medical and healthcare industry through the distribution of printed and audio promotional materials and by rendering sales promotion advice: offering technical assistance in the establishment and/or marketing of pharmaceutical or medical products; developing promotional campaigns for business; business marketing consulting services; business information services; business information services provided on-line from computer database management or the Internet; business information relating to the medical and healthcare industry; business information management relating to the medical and healthcare industry; business consultation; business management; business administration; business management consultation; business management information on a wide variety of topics to service providing professionals; business consultancy services; business marketing consulting services; business networking; business planning; business research and surveys; business services provided to the healthcare industrythe collectionreportinganalysis of healthcare data for business purposesfacilities management of technical operations; commercial information agencies providing business informationmarketing or demographic data; business investigations; arranging and conducting business conferences; facilitating business meetings; business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trialsmedicinebiotechnologylife sciences and pharmaceuticals for business purposes; product endorsement assistance; providing business intelligence services in the medical and healthcare fields; database management; compiling of information into computer databases; market analysis for business purposes ; arranging and conducting business conferences
Classe 41
Education servicesproviding classesworkshopstutorialsseminars in relation to developments in the fields of medicinebiotechnologylife sciences and pharmaceuticals and distribution of training materials in connection therewith; arrangingorganizingconductinghosting social entertainment events; organising sporting and cultural activities; Non-downloadable electronic publications in the fields of medicinebiotechnologylife sciences and pharmaceuticals; arranging of seminars relating to business; providing classesseminarsworkshops in the field of business education; conducting of courses relating to business management; publishing services in relation to booksmagazinesjournalsarticlesbulletinsdigital videoaudio and multimedia; providing on-line electronic publishing in relation to booksmagazinesjournalsarticlesbulletinsdigital videoaudio and multimedia; publication of journals and newsletterspublication of newsletters and journals relating to the medical and healthcare industry; publication of journals and newsletters directed at healthcare professionals; provision of reprints from medical journals; publication of communication materialsproduct monographsabstract booksscientific and promotional postersspeaker slidesnewsletters and highlights bulletinsproceedings and supplementssingle-sponsored journalstraining manuals; electronic publishing servicespublication of text and graphic works of others on CD or on-line matters of medical and healthcare services; information relating to educationtraining or publishing provided on-line from computer databases of the Internet; informationadvisory and consultancy services relating to the aforementioned services
Publicações
Histórico de despachos e eventos da marca no USPTO.
72 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
29/12/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
29/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/12/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
19/09/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/09/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/09/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17/09/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/09/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/09/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/09/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
22/09/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
22/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/02/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
14/09/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
14/09/2022
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
14/09/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/09/2022
E815
TEAS SECTION 8 & 15 RECEIVED
18/03/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
18/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/07/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
27/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/07/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22/09/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/08/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
22/09/2015
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
17/08/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/08/2015
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/07/2015
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/07/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/04/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2015
PUBO
PUBLISHED FOR OPPOSITION
03/03/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/01/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/01/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/01/2015
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
23/01/2015
GNSI
INQUIRY TO SUSPENSION E-MAILED
23/01/2015
CNSI
SUSPENSION INQUIRY WRITTEN
23/01/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/01/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/07/2014
GNSL
LETTER OF SUSPENSION E-MAILED
10/07/2014
CNSL
SUSPENSION LETTER WRITTEN
10/07/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2014
ALIE
ASSIGNED TO LIE
04/07/2014
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/06/2014
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/01/2014
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/01/2014
CNSI
SUSPENSION INQUIRY WRITTEN
02/01/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
25/06/2013
GNSL
LETTER OF SUSPENSION E-MAILED
25/06/2013
CNSL
SUSPENSION LETTER WRITTEN
25/06/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/06/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/06/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/06/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/12/2012
GNRT
NON-FINAL ACTION E-MAILED
20/12/2012
CNRT
NON-FINAL ACTION WRITTEN
20/12/2012
DOCK
ASSIGNED TO EXAMINER
19/12/2012
MPMK
NOTICE OF PSEUDO MARK MAILED
07/09/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2012
NWAP
NEW APPLICATION ENTERED
31/08/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EVALUATE MEDTECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.